Experience

Mirati Therapeutics
• United States
• Biotechnology Research
• 300 - 400 Employee
• National Access Director

  • Oct 2021 - Present


Clovis Oncology

• United States
• Biotechnology Research
• 1 - 100 Employee

• National Access Director

  • Mar 2021 - Oct 2021

  Established strategic business partnerships with key National Payers, National PBMs, PBM owned GPOs, and PBM owned Specialty Pharmacies. • Focus accounts include ESI, Cigna, Humana, Prime Therapeutics, WellCare/Centene, Magellan, PerformRX, Highmark BCBS, Florida Blue, BCBS of South Carolina, and UPMC. GPO and Specialty Pharmacy accounts include Ascent and Accredo. • Corporate lead in developing the first 340B Strategy for Clovis. • Provide Rubraca/PARPi market trends and competitive landscape overviews to relevant internal and external stakeholders.



Tricida, Inc.

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Corporate Account Director

  • Nov 2019 - Mar 2021

  Responsible for establishing strategic business partnerships with key Regional Payers, National Payers, and PBMs while introducing a first in category product for chronic kidney disease. • Focus accounts include WellCare, Magellan, Prime, ProCare Rx, PerformRx, BCBS North Carolina, BCBS South Carolina, BCBS Tennessee, Florida Blue, Capital Blue, Geisinger, Sentara/Optima, and the State Medicaid plans in NC, SC, GA, TN, VA and WV. • Deliver product value proposition, clinical presentations, and value messaging to various payer decision makers including pharmacy, medical, and care management. • Provide market insights to relevant internal and external stakeholders regarding health care, payer and category trends. • Communicate with field sales leadership to convey payer coverage and the reimbursement landscape to ensure clear and actionable pull-through strategies.



TESARO, Inc.

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Director - Corporate Accounts

  • Sep 2016 - Nov 2019

  Responsible for establishing strategic business partnerships with key Regional and National Payers and PBMs in order to facilitate patient access and reimbursement for TESARO'S emerging portfolio of innovative oncology treatments. • Launched Zejula, a PARPi for ovarian cancer. • Secured full access for Zejula with Regional and National Payers, including ESI, WellCare, Magellan, Florida Blue, BCBS North Carolina, BCBS South Carolina, BCBS Tennessee, and BCBS Louisiana. • Partnered with Sales Leadership to ensure that pull-through was maximized down to the territory level. • Team Lead for Market Access and Sales Analytics



AstraZeneca/PUBLICIS TOUCHPOINT SOLUTIONS

• Regional Director/Market Access

  • Jan 2015 - Sep 2016

  Hired to build a team of 13 representatives in North and South Carolina to launch Movantik, a new class of oral drugs for Opioid Induced Constipation. • Finished FY 2015 #3 nationally for Movantik performance. • Managed Markets Lead/Liaison to the National Sales Director. • Earned Outstanding Leadership Award for Q2 and Q3 FY 2016. Hired to build a team of 13 representatives in North and South Carolina to launch Movantik, a new class of oral drugs for Opioid Induced Constipation. • Finished FY 2015 #3 nationally for Movantik performance. • Managed Markets Lead/Liaison to the National Sales Director. • Earned Outstanding Leadership Award for Q2 and Q3 FY 2016.



Forest Pharmaceuticals

• Pharmaceutical Manufacturing
• 100 - 200 Employee

• Managed Markets Account Manager (Regional/National)

  • 2005 - 2014

  Promoted to devise and implement sales and account management strategies to ensure achievement of sales goals and formulary access by targeting and developing relationships with key decision makers within Regional and National Managed Care Organizations, State Medicaid, PBM, and Integrated Delivery System accounts in North Carolina, South Carolina, Georgia, Florida, Tennessee, and Virginia.Represented Lexapro (depression), Namenda (Alzheimer’s), Savella (fibromyalgia), and Bystolic (cardiovascular) at BCBS of South Carolina, BCBS of North Carolina, BCBS of Tennessee, Amerigroup, Sentara-Optima, NC, SC, and VA State Medicaid, United Healthcare, Magellan Medicaid (PBM), and Coventry Healthcare.Partnered with brand teams, marketing, legal, and contracting personnel to devise pull-through programs, contracting strategies, and rebate initiatives. Secured Tier 2 Preferred Status for Lexapro on Coventry/First Health Medicare Part D Plans• Worked with Magellan (First Health Medicaid PBM) to secure mutually favorable contracts for Lexapro, Namenda, Savella, and Bystolic.• Launched and garnered Tier 2 Preferred status for Bystolic on BCBS of North Carolina.• Gained Tier 2 Preferred Agent status for Savella, Bystolic, and Lexapro on BCBS of South Carolina.• Partnered with BCBS of SC to source and secure key thought leaders to deliver programs focused on recognizing depression in the workplace and improving HEDIS scores.• Selected as 1 of 27 out of 250 managers to participate in the first-ever Advanced Leaders Program. • Received the Outstanding Leadership award during position tenure for positive account results and Managed Markets Pull-Through leadership.

• Specialty Divisional Sales Manager

  • 2004 - 2005

  Chosen to partner directly with two management teams consisting of 8 divisional managers to develop and implement strategies to accomplish divisional goals. Established goals per product / per quarter, analyzed and tracked performance, and managed product pull-through budgets. Managed, coached, and mentored a team of 10 Specialty Representatives, covering Psychiatrists, Cardiologists, and Neurologists in NC, SC, VA, and WV.• Spearheaded first-ever company entrance into the Alzheimer’s disease state by successfully launching Namenda, finishing the year in the Top 25% nationally.• Launched Campral, for alcohol dependency, finishing the year at #6 out of 28 Specialty Divisions.• Earned two Outstanding Leadership awards for creating and rolling out winning sales programs.

• Divisional Sales Manager

  • Jan 2001 - Dec 2003

  Hire, train, supervise, and evaluate a team of 10 field sales representatives charged with calling on primary care and specialty physicians covering products in the pulmonary, neurological, and cardiovascular disease states. These products include Namenda, Celexa, Lexapro, Benicar, and Bystolic.• Earned President’s Club award in FY 2003 with a #2 ranking out of 52 Divisional Sales Managers company-wide.• Successfully launched Benicar, placing in the Top 10 in Benicar sales during FY 2003.• Honored with the Outstanding Sales Management award in 2002 for ranking #7 out of 52 DSMs.

• Regional Sales Trainer

  • 2000 - 2001

  Developed and presented classroom and ride-a-long sales training sessions in cooperation with marketing and brand management for initial and tenured field sales representatives in the Southeast Area Business Unit, educating up to 10 individuals per program. This included initial product training and Managed Markets Education and Pull-Thru training.

• Sales Representative

  • 1997 - 1999

  Represented products in the respiratory, cardiovascular, antibiotic, and CNS classes to primary care, psychiatry, cardiology, pulmonary, and OB/GYN physicians in South Carolina to increase market share. • Launched Celexa and achieved 10% market share (only 1 of 10 Sales Representatives) in the country within six months. • Advanced from #300 out of 485 representatives at position commencement to #6 out of 600 by second-year with company. • Received President’s Club Award (Top 2% of Sales Force) and the Representative of the Year Award for the Southeast Region during FY 1999.